359 / 884
High risk patients: EBRT + seeds (+ADT)
(Stone 2009)
Survival by dose group for Gleason 8–10
Treatment: EBRT + seed implant + ADT
Overall survival
•
< 200 Gy 86.6%
•
200–220 Gy 89.4%
•
> 220 Gy 94.6%
(
p
< 0.05)
Overall survival
•
< 200 Gy 86.6%
•
200–220 Gy 89.4%
•
> 220 Gy 94.6%
(
p
< 0.05)